De Yong Wen
Chief Executive Officer at SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Net worth: 611 566 $ as of 29/04/2024
De Yong Wen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SINOPHARM GROUP CO. LTD. | Director/Board Member | 31/08/2017 | - |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 08/05/2019 | - |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Director/Board Member | 09/08/2022 | - |
| Chief Executive Officer | 31/05/2022 | - | |
| Corporate Officer/Principal | - | - | |
| President | - | 31/05/2022 | |
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | 27/07/2022 | - |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chairman | 09/07/2019 | - |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 19/01/2020 | - |
Career history of De Yong Wen
Former positions of De Yong Wen
| Companies | Position | Start | End |
|---|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Board Member | - | - |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Board Member | - | - |
Training of De Yong Wen
| West China University of Medical Sciences | Undergraduate Degree |
| Donghua University | Masters Business Admin |
Statistics
International
| China | 11 |
Operational
| Director/Board Member | 7 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
| SINOPHARM GROUP CO. LTD. | Distribution Services |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
- Stock Market
- Insiders
- De Yong Wen
- Experience
